Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Fibrinogen  [Clear All Filters]
Chen H, Huffman JE, Brody JA, et al. "Efficient Variant Set Mixed Model Association Tests for Continuous and Binary Traits in Large-Scale Whole-Genome Sequencing Studies." Am J Hum Genet. 2019;104(2):260-274.
Walker KA, Walston J, Gottesman RF, Kucharska-Newton AMaria, Palta P. "Midlife Systemic Inflammation Is Associated With Frailty in Later Life: The ARIC Study." J Gerontol A Biol Sci Med Sci. 2019;74(3):343-349.
Walker KA, Gottesman RF, Wu A, et al. "Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study." Neurology. 2019;92(11):e1256-e1267.
Brody JA, Morrison AC, Bis JC, et al. "Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology." Nat Genet. 2017;49(11):1560-1563.
Schreiner PJ, Appiah D. "Gamma prime (γ') fibrinogen and carotid intima-media thickness: the Atherosclerosis Risk in Communities study." Blood Coagul Fibrinolysis. 2017;28(8):665-669.
Walker KA, Hoogeveen RC, Folsom AR, et al. "Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study." Neurology. 2017;89(22):2262-2270.
de Vries PS, Chasman DI, Sabater-Lleal M, et al. "A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration." Hum Mol Genet. 2016;25(2):358-70.
Folsom AR, Tang W, George KM, Heckbert SR, Maclehose RF, Cushman M. "Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)." Thromb Res. 2016;139:44-9.
Tin A, Grams ME, Maruthur NM, et al. "Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study." Clin J Am Soc Nephrol. 2015;10(5):784-90.
Huffman JE, de Vries PS, Morrison AC, et al. "Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF." Blood. 2015;126(11):e19-29.
Rifai MAl, Schneider ALC, Alonso A, et al. "sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study." J Diabetes Complications. 2015;29(2):180-5.
Kaptoge S, Di Angelantonio E, Pennells L, et al. "C-reactive protein, fibrinogen, and cardiovascular disease prediction." N Engl J Med. 2012;367(14):1310-20.
Alonso A, Tang W, Agarwal SK, Soliman EZ, Chamberlain AM, Folsom AR. "Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study." Int J Cardiol. 2012;155(2):217-22.
Prizment AE, Anderson KE, Visvanathan K, Folsom AR. "Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study." Cancer Epidemiol Biomarkers Prev. 2011;20(2):297-307.
Dehghan A, Yang Q, Peters A, et al. "Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts." Circ Cardiovasc Genet. 2009;2(2):125-33.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. "Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2009;53(4):596-605.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. "Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood." J Epidemiol Community Health. 2008;62(6):484-91.
Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD, Cushman M. "Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort." Stroke. 2008;39(8):2268-73.
Rasmussen-Torvik LJ, Cushman M, Tsai MY, et al. "The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study." Thromb Res. 2007;121(1):1-7.
Cushman M, Cornell A, Folsom AR, et al. "Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis." Thromb Res. 2007;121(3):339-45.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. "Early-life and adult socioeconomic status and inflammatory risk markers in adulthood." Eur J Epidemiol. 2007;22(1):55-66.
Wong TY, Klein R, Amirul Islam FM, et al. "Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study." Am J Ophthalmol. 2007;143(6):970-6.
Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH, Folsom AR. "Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study." Stroke. 2006;37(10):2493-8.
Liao D, Heiss G, Chinchilli VM, et al. "Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study." J Expo Anal Environ Epidemiol. 2005;15(4):319-28.
Folsom AR, Golden S H, Boland LL, Szklo M. "Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women." Eur J Epidemiol. 2005;20(12):1015-22.
Wattanakit K, Folsom AR, Chambless LE, Nieto JF. "Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2005;149(4):606-12.
Wattanakit K, Folsom AR, Selvin E, et al. "Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2005;180(2):389-97.
Rose KM, Carson AP, Sanford CP, et al. "Migraine and other headaches: associations with Rose angina and coronary heart disease." Neurology. 2004;63(12):2233-9.
Folsom AR, Desvarieux M, Nieto JF, Boland LL, Ballantyne CM, Chambless LE. "B vitamin status and inflammatory markers." Atherosclerosis. 2003;169(1):169-74.
Duncan BB, Schmidt M I, Chambless LE, Folsom AR, Heiss G. "Inflammation markers predict increased weight gain in smoking quitters." Obes Res. 2003;11(11):1339-44.
Knuiman MW, Folsom AR, Chambless LE, Liao D, Wu KK. "Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study." Neuroepidemiology. 2001;20(2):96-104.
Folsom AR, Aleksic N, Ahn C, Boerwinkle E, Wu KK. "Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2001;11(3):166-70.
Folsom AR, Wu KK, Rasmussen M, Chambless LE, Aleksic N, Nieto FJ. "Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 2000;20(2):601-6.
Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G. "Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities." Obes Res. 2000;8(4):279-86.
Metcalf PA, Folsom AR, Davis CE, Wu KK, Heiss G. "Haemostasis and carotid artery wall thickness in non-insulin dependent diabetes mellitus." Diabetes Res Clin Pract. 2000;47(1):25-35.
Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. "Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Ann Intern Med. 2000;133(2):81-91.
Folsom AR, Peacock JM, Nieto FJ, et al. "Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study." J Hypertens. 1998;16(11):1579-83.
Iso H, Koike KA, Folsom AR, et al. "Lipoprotein(a) and its correlates in Japanese and U.S. population samples." Ann Epidemiol. 1996;6(4):324-30.
Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. "Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors." Atherosclerosis. 1991;91(3):191-205.
"Seasonal fibrinogen fluctuations among elderly people." Lancet. 1991;338(8767):629-30.